Ziprasidone, a benziso-thiazolyl-piperazine derivative, is an atypical antipsychotic effective across positive, negative, and affective symptoms of schizophrenia, with fewer extrapyramidal, cognitive, prolactin-related, or anticholinergic side effects [65,66]. This evidence concerns the gene PRL and schizophrenia.